INTERFERON AND NATURAL KILLER ACTIVITY IN MULTIPLE MYELOMA. LACK OF CORRELATION BETWEEN INTERFERON-INDUCED ENHANCEMENT OF NATURAL KILLER ACTIVITY AND CLINICAL RESPONSE TO HUMAN INTERFERON-ALPHAEINHORN S; AHRE A; BLOMGREN H et al.1982; INT. J. CANCER; ISSN 0020-7136; CHE; DA. 1982; VOL. 30; NO 2; PP. 167-172; BIBL. 26 REF.Article

INTERFERON THERAPY IN MYELOMATOSISMELLSTEDT H; AHRE A; BJORKHOLM M et al.1979; LANCET; GBR; DA. 1979; NO 8110; PP. 245-247; BIBL. 14 REF.Article

Pretreatment serum β₂-microglobulin in multiple myelomaBRENNING, G; SIMONSSON, B; KALLANDER, C et al.British journal of haematology. 1986, Vol 62, Num 1, pp 85-93, issn 0007-1048Article

T CELLS IN MONOCLONAL GAMMOPATHIESMELLSTEDT H; HOLM G; PETTERSSON D et al.1982; SCAND. J. HAEMATOL.; ISSN 0036-553X; DNK; DA. 1982; VOL. 29; NO 1; PP. 57-64; BIBL. 32 REF.Article

Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myelomaBRENNING, G; AHRE, A; NILSSON, K et al.Scandinavian journal of haematology. 1985, Vol 35, Num 5, pp 543-549, issn 0036-553XArticle

Evaluation of serum deoxythymidine kinase as a marker in multiple myelomaSIMONSSON, B; KALLANDER, C. F. R; BRENNING, G et al.British journal of haematology. 1985, Vol 61, Num 2, pp 215-224, issn 0007-1048Article

IgA subclass distribution in paraproteinemias: suggestion of an IgG-IgA subclass switch patternHAMMARSTROM, L; MELLSTEDT, H; PERSSON, M. A. A et al.Acta pathologica, microbiologica et immunologica Scandinavica. Section C. Immunology. 1984, Vol 92, Num 4, pp 207-211, issn 0108-0202Article

Biochemical markers in multiple myeloma: a multivariate analysisSIMONSSON, B; KALLANDER, C. F. R; BRENNING, G et al.British journal of haematology. 1988, Vol 69, Num 1, pp 47-53, issn 0007-1048Article

Blood clonal B cell excess at diagnosis in multiple myeloma: relation to prognosisOSTERBORG, A; NILSSON, B; BJORKHOLM, M et al.Scandinavian journal of haematology. 1987, Vol 38, Num 2, pp 173-178, issn 0036-553XArticle

Alpha interferon treatment of patients with hairy-cell leukaemiaHAGBERG, H; ALM, G; BJORKHOLM, M et al.Scandinavian journal of haematology. 1985, Vol 35, Num 1, pp 66-70, issn 0036-553XArticle

Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple mycloma patients stage III. A randomized study from MGCSOSTERBORG, A; AHRE, A; KILLANDER, A et al.European journal of haematology. 1989, Vol 43, Num 1, pp 54-62, issn 0902-4441Article

Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the myeloma group of central SwedenAHRE, A; BJORKHOLM, M; KARNSTROM, L et al.Cancer treatment reports. 1984, Vol 68, Num 11, pp 1331-1338, issn 0361-5960Article